Amgen Inc. buy BMO Capital Markets
Start price
19.12.23
/
50%
€253.60
Target price
19.12.24
€297.31
Performance (%)
12.76%
Price
31.05.24
€281.80
Summary
This prediction is currently active. The BUY prediction by BMO_Capital_Markets currently has a performance of 12.76%. Dividends of €4.16 are taken into consideration when calculating the performance. This prediction currently runs until 19.12.24. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Amgen Inc. | -0.035% | -0.035% |
iShares Core DAX® | -0.552% | 3.405% |
iShares Nasdaq 100 | -1.415% | 4.613% |
iShares Nikkei 225® | -0.877% | -1.396% |
iShares S&P 500 | -0.415% | 3.338% |
Comments by BMO_Capital_Markets for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to an "outperform" rating. They now have a $326.00 price target on the stock, up previously from $286.00.
Ratings data for AMGN provided by MarketBeat